Ulka N. Vaishampayan, MD of Karmanos Cancer Institute discusses how immunotherapies are being integrated renal cell carcinoma treatment. She states that immunotherapy currently is in second or third line after targeted therapy, but is becoming more of a frontline therapy treatment for kidney cancer. This was recorded at the 2017 Genitourinary Cancers Symposium (Annual Meeting GU) in Orlando, Florida.
Role of Immunotherapy is Expanding in Renal Cell Carcinoma Treatment
